期刊文献+

BiPAP呼吸机治疗AECOPD合并呼吸衰竭临床效果观察 被引量:11

Clinical Effect of BiPAP Ventilation Therapy in AECOPD with Respiratory Failure
下载PDF
导出
摘要 目的 探讨双水平气道正压无创通气(BiPAP)在慢性阻塞性肺疾病急性加重期(AECOPD)伴Ⅱ型呼吸衰竭中的临床疗效.方法 将2012年1月至2013年1月在武汉大学人民医院重症医学科住院治疗的AECOPD伴Ⅱ型呼吸衰竭的120例患者,采用随机数字表法分为吸氧治疗组和呼吸机组,各60例.在常规治疗的基础上,吸氧治疗组60例给予1 ~2 L/min低流量吸氧;呼吸机组60例给予BiPAP呼吸机辅助治疗,比较两组患者的血气分析指标、插管率及临床效果.结果 两组患者血0气分析中的pH值、氧分压和二氧化碳分压值较治疗前均明显改善(P<0.05);呼吸机组的有效率达91.67%,显著高于吸氧治疗组的76.67%(P<0.05);而气管插管率及病死率低于吸氧治疗组(8.33% vs 26.67%)、(1.67% vs 11.67%),差异有统计学意义(P<0.05).结论 使用BiPAP呼吸机治疗时,血气分析改善迅速、预后良好,值得在临床中推广,但需注意呼吸衰竭的严重程度. Objective To explore the clinical efficacy of bi-level positive airway pressure (BiPAP) noninvasive ventilation in patients with chronic obstructive pulmonary disease with acute exacerbation (AECO- PD) combined with type Ⅱ respiratory failure. Methods A total of 120 patients with AECOPD combined with type Ⅱ respiratory failure treated and hospitalized at the Critical Care Medicine Department of People's Hospital of Wuhan University during Jan. 2012 and Jan. 2013 were included,, they were randomly divided into oxygen therapy group and ventilator group by random balloting method,60 cases in each group. On the basis of conventional therapy, oxygen therapy group was given 1-2 L/min low-flow oxygen ; ventilator group was treated with BiPAP ventilator-assisted therapy. The blood gas analysis, intubation rate and clinical results of the two groups were compared. Results The pH value of blood gas analysis, oxygen and carbon dioxide partial pressure values of the two groups were significantly improved compared with before treatment (P 〈0.05 ) ;effective rate of the ventilator group was 91.67%, significantly higher than the 76.67% of the oxygen therapy group ( P 〈 0.05 ) ; while endotracheal intabation rate and mortality were lower than oxygen therapy group, with statistically significant differences [ ( 8.33% vs 26. 67% ), ( 1.67% vs 11.67% ), ( P 〈 0.05 ) ]. Conclusion BiPAP ventilation therapy enables blood gas analysis to improve rapidly,with good prognosis,thus is worthy of promotion in clinical,while the severity of respiratory failure should be noticed.
作者 鞠涛 周青山
出处 《医学综述》 2014年第13期2436-2438,共3页 Medical Recapitulate
关键词 慢性阻塞性肺疾病 急性加重期 呼吸衰竭 无创正压通气 Chronic obstructive pulmonary disease Acute exacerbation Respiratory failure Noninvasive positive pressure ventilation
  • 相关文献

参考文献9

二级参考文献95

共引文献8287

同被引文献105

  • 1慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中国医学前沿杂志(电子版),2014,6(2):67-80. 被引量:2032
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261. 被引量:1793
  • 3Roy B,Cordova FC, Travaline JM,et al. Full face maskfor noninvasive positive -pressure ventilation in patientswith acute respiratory failure[J]. J Am Osteopath Assoc,2007,107(4):148-156. 被引量:1
  • 4Scala R,Nava S, Conti G,et al. Noninvasive versus con-ventional ventilation to treat hypercapnic encephalopathyin chronic obstructive pulmonary disease[J]. Intensive CareMed,2007,33(2):2101-2108. 被引量:1
  • 5Ciftci F,Sen E,Akkoca YO,et al.A comparison of cardiopulmonary exercise test and 6 minute walking test in determination of exercise capacity in chronic obstructive pulmonary disease[J].Tuberk Toraks,2014,62(4):259-266. 被引量:1
  • 6Kim M,Cha SI,Choi KJ,et al.Prognostic value of serum growth differentiation factor-15in patients with chronic obstructive pulmonary disease exacerbation[J].Tuberc Respir Dis(Seoul),2014,77(6):243-250. 被引量:1
  • 7Young J, Donahue M, Farquhar M, et al. Attitudes to using opioids to treat dyspnea in advanced COPD:A qualitative study of family physicians and respiratory therapists[J]. Can Fam Physician, 2012,58 (7) : 401-407. 被引量:1
  • 8Antman EM,Anbe DT,Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST eleva- tion myocardial infarction: A report of the American col- lege of cardiology/american heartassociation task force on < practice guidelines(Committee to revise the 1999 guidelines for the management of patients with a cute myocardial in- farction)[J]. J Am CollCardiol,2004,44(3):El-E211. 被引量:1
  • 9Jung KS, Park HY, Park SY, et al. Comparison of tiotropi- um plus fluticasone propionate/salmeterol with tiotropiu- min COPD:A randomized controlled study[J]. Respir Med, 2012,106(3) : 382-389. 被引量:1
  • 10Loring SH, Garcia-Jacques M, Malhotra A. Pulmonarycharacteristics in COPD and mechanisms of increased work of breathin~J]. J Appl Physiol,2009,107(1).309-314. 被引量:1

引证文献11

二级引证文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部